Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Horst Dürkop"'
Autor:
Liudmila Lobastova, Marcus Lettau, Felix Babatz, Thais Dolzany de Oliveira, Phuong-Hien Nguyen, Bianca Alves Pauletti, Astrid C. Schauss, Horst Dürkop, Ottmar Janssen, Adriana F. Paes Leme, Michael Hallek, Hinrich P. Hansen
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
CD30, a member of the TNF receptor superfamily, is selectively expressed on a subset of activated lymphocytes and on malignant cells of certain lymphomas, such as classical Hodgkin Lymphoma (cHL), where it activates critical bystander cells in the tu
Externí odkaz:
https://doaj.org/article/ee4ad5abc83c476f806f4f05d2d13b45
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 144:499-507
To analyze the impact of TNFα or IL2 on human lymphocytes in vitro and the anti-tumor and immune-modifying effects of L19-IL2 and L19-TNFα on subcutaneously growing J558L myeloma in immunocompetent mice. PBMCs from three healthy volunteers were inc
Autor:
Hendrik Fuchs, Alexander Weng, Cheenu Bhargava, Matthias F. Melzig, Horst Dürkop, Xiangli Zhao
Publikováno v:
Molecular Oncology
Targeted cancer therapy provides the basis for the arrest of tumor growth in aggressive pancreatic carcinoma, however, a number of protein-based targeted toxins lack efficacy due to insufficient endosomal escape after being endocytosed. Therefore, we
Autor:
Marcia Moss, Paola Zigrino, Daniel Bachurski, Maria Dams, Adriana Franco Paes Leme, Gisela Schön, Michael von Bergwelt-Baildon, Patricia C. Grenzi, Elke Pogge von Strandmann, Andreas Engert, Bruno Aquino, Ahmad Trad, Hinrich P. Hansen, Michael Hallek, Maximillian Tator, Horst Dürkop, Katrina S. Reiners, Joaquim Grotzinger
Publikováno v:
Oncotarget
// Hinrich P. Hansen 1 , Ahmad Trad 2 , Maria Dams 1 , Paola Zigrino 3 , Marcia Moss 4 , Maximilian Tator 1 , Gisela Schon 1 , Patricia C Grenzi 1 , Daniel Bachurski 1 , Bruno Aquino 5 , Horst Durkop 6 , Katrin S Reiners 1 , Michael von Bergwelt-Bail
Autor:
Roshanak Bob, Andreas Roth, Anna Streubel, Christian Erck, Horst Dürkop, Hans-Michael Kvasnicka, Harald Stein, Henrik Martens, Dietrich Kämpfe
Publikováno v:
Leukemia
Recent advances in the diagnostic of myeloproliferative neoplasms (MPNs) discovered CALRETICULIN (CALR) mutations as a major driver in these disorders. In contrast to JAK2 mutations being mainly associated with polycythaemia vera, CALR mutations are
Autor:
Roger Gilabert-Oriol, Alexander Weng, Mayank Thakur, Matthias F. Melzig, Nicola Beindorff, Mathias Lukas, Hendrik Fuchs, Horst Dürkop, Winfried Brenner, Benedicta von Mallinckrodt
Publikováno v:
Future Oncology. 10:2161-2175
ABSTRACT Aims: The intention of this work was to lift saponin supported tumor targeted therapies onto the next level by using targeted toxins in nude mice xenotransplant models. Materials & methods: Combined application of dianthin coupled to EGF and
Autor:
Leonardo Giovannoni, Horst Dürkop, Ricarda Locher, Paola Anna Erba, Emilio Bombardieri, Hans D. Menssen, Burkhard Hirsch, Dario Neri
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 140:35-43
The extradomain B of fibronectin (ED-B) is a promising vascular target for selective pharmacodelivery in cancer patients. We analyzed a large series of prostatectomies from patients with prostate cancer, hyperplastic prostate disease, and normal pros
Autor:
Horst Dürkop, Lothar Lucka, Burkhard Hirsch, Ming-Qing Du, Florian Wagner, Maria Grünbaum, Yingwen Bi, Harald Stein
Publikováno v:
Histopathology. 60:E19-E27
Hirsch B, Grunbaum M, Wagner F, Bi Y, Lucka L, Du M-Q, Stein H & Durkop H (2012) Histopathology 60, E19–E27 A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology Aims: A20 (TNFAIP3) is a nuclear factor-κB
Autor:
Wolfram Sterry, Jürgen Eberle, Frank K. Braun, M.E. Kadin, Chalid Assaf, Nadya Al-Yacoub, Horst Dürkop, Burkhard Hirsch
Publikováno v:
Der Pathologe. 31:193-198
Stimulation of the TNF receptors CD30 and CD95 exerts opposite effects. Crosstalk of both receptors is unknown. We aimed to reveal regulatory mechanisms of CD30-induced effects on CD95 signaling of cALCL cell lines. "CD30/CD95 crosstalk analysis" was
Autor:
Frank K. Braun, Horst Dürkop, Jürgen Eberle, Wolfram Sterry, Marshall E. Kadin, Chalid Assaf, Nadya Al-Yacoub, Burkhard Hirsch
Publikováno v:
Journal of Investigative Dermatology. 130:826-840
Death ligands, including TNF-alpha, CD95L/FasL, and TRAIL, mediate safeguard mechanisms against tumor growth and critically contribute to lymphocyte homeostasis. We investigated death receptor-mediated apoptosis and CD30/CD95 crosstalk in four CD30-p